Uber may have to look beyond Silicon Valley to find a replacement for the company's hard-charging founder.
Once millennials get in on an upward trend, count on the market to head in the opposite direction.
Samsung's Bioepis unit seeks final approval in Europe of a rheumatoid arthritis drug to compete with Humira.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.